Skip to main content

Home/ Cancer/ Group items tagged OncoVEX_GM-CSF

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Matti Narkia

BioVex To Report Phase I/II Clinical Trial Results For The Front Line Treatment Of Head... - 0 views

www.medicalnewstoday.com/...150300.php

2009 May medicalnewstoday news head_and:neck cancer head_and:neck_cancer hnca scchn scc ASCO meeting OncoVEX GM-CSF chemoradiotherapy OncoVEX_GM-CSF BioVex oncolytic_virus oncolytic_viruses oncolytic virus viruses virotherapy phase_I phase_II trial

shared by Matti Narkia on 16 May 09 - Cached
  • Matti Narkia on 16 May 09
     
    BioVex Inc, a company developing next generation biologics for the treatment and prevention of cancer and infectious disease, announced that the results from a Phase I/II combination study in previously untreated patients with head and neck cancer will be presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting, which will take place May 29, 2009 - June 2, 2009 in Orlando, FL.
1 - 1 of 1
Showing 20▼ items per page